SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery

Sponsor
Medipol University
Study ID
NCT07436806
Status
Recruiting
Apply to this trial

Conditions

  • Chronic Post-thoracotomy Pain
  • Neuropathic Pain
  • Postoperative Pain, Acute

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • SPS block — DRUG
    30 mL of 0.25% Bupivacaine will be injected into the plane between the Serratus Posterior Superior muscle and the intercostal muscles at the scapular level.
  • Surgical Intercostal Blockade. — DRUG
    At the end of the operation, the surgeon will perform an injection of a total of 30 mL of 0.25% Bupivacaine into three intercostal nerves above and below the incision site under direct thoracoscopic visualization.

Study Details

This study aims to evaluate the efficacy of ultrasound-guided Serratus Posterior Superior (SPS) block compared to surgeon-administered intercostal blockade in preventing chronic pain at 3, 6, and 12 months following Video-Assisted Thoracoscopic Surgery (VATS).

Key Dates

First listed
Feb 27, 2026
Start date
Mar 1, 2026
Status verified
Mar 2026
Primary completion
Nov 20, 2026
Completion
Dec 10, 2026

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: SPS Block Group
    SPS Block will be performed at the end of the surgery
  • Active Comparator: Surgical Intercostal Blockade Group
    Surgical Intercostal Blockade will be performed at the end of the surgery by the surgeon

Primary Outcome Measure

Incidence and severity of Chronic Post-Thoracotomy Pain (CPTP) [ Time Frame: Incidence and severity of Chronic Post-Thoracotomy Pain (CPTP) at 3, 6, and 12 months post-surgery. ]

Central Contacts

Related Studies